CAPGEMINI 103.000 € (+0,29 %)
HYDROGEN REFUELING 1.470 € (-6,73 %)
PHILIPS KON 22.390 € (+2,14 %)
KLARSEN 0.548 € (+83,89 %)
BOIRON 27.400 € (+4,58 %)
PROLOGUE 0.254 € (+0,79 %)
STMICROELECTRONICS 46.015 € (+2,90 %)
KERING 232.650 € (+0,04 %)
TETRAGON FIN GRP 13.300 € (-2,21 %)
SOITEC 126.950 € (+12,25 %)
VEOLIA ENVIRON. 35.940 € (+3,25 %)
MAGNUM 12.440 € (+11,45 %)
PAULIC MEUNERIE 1.580 € (+11,27 %)
ING GROEP N.V. 24.755 € (+3,66 %)
POSTNL 0.948 € (+0,69 %)
GASCOGNE 2.360 € (+9,26 %)
VALLOUREC 25.650 € (+2,35 %)
CIECHARGEURSINVEST 8.440 € (-2,54 %)
AIRBUS 174.880 € (+0,15 %)
ASML HOLDING 1 222.400 € (+2,50 %)
PROSUS 41.070 € (+1,03 %)
LVMH 451.400 € (+0,66 %)
SHELL PLC 38.510 € (+1,80 %)
VINCI 128.500 € (+1,86 %)
IMCD 100.150 € (+3,01 %)
CVC CAPITAL 12.950 € (+3,52 %)
TECHNIP ENERGIES 40.300 € (-0,05 %)
FDJ UNITED 23.100 € (-1,53 %)
E PANGO 0.190 € (-23,08 %)
ALSTOM 17.080 € (+4,27 %)
AMUNDI 82.200 € (+1,29 %)
ASR NEDERLAND 64.560 € (+0,91 %)
TOTALENERGIES 79.290 € (+1,35 %)
SARTORIUS STED BIO 156.700 € (+3,43 %)
EXOR NV 66.800 € (+0,91 %)
CARMILA 16.980 € (-0,12 %)
BE SEMICONDUCTOR 247.200 € (+3,26 %)
DANONE 66.740 € (+0,97 %)
BUREAU VERITAS 26.060 € (+0,81 %)
EXAIL TECHNOLOGIES 123.600 € (-0,24 %)
HEINEKEN HOLDING 60.400 € (+1,85 %)
ARKEMA 62.000 € (+1,06 %)
ASM INTERNATIONAL 830.600 € (+2,57 %)
IPSEN 167.000 € (+2,52 %)
COVIVIO 56.200 € (+0,54 %)
SANOFI 79.820 € (+1,92 %)
NEXANS 158.100 € (+3,27 %)
SAINT GOBAIN 77.640 € (+1,54 %)
SOCIETE GENERALE 68.440 € (-3,59 %)
AHOLD DEL 40.020 € (+0,58 %)
LEGRAND 151.800 € (+1,57 %)
FUGRO 12.350 € (+7,11 %)
GECINA 71.850 € (+0,42 %)
FRANCAISE ENERGIE 38.000 € (-0,91 %)
STELLANTIS NV 6.215 € (-6,40 %)
KAUFMAN ET BROAD 27.650 € (+0,55 %)
NN GROUP 74.300 € (+0,92 %)
ISPD 1.740 € (0,00 %)
EKINOPS 2.490 € (-2,92 %)
MYHOTELMATCH 0.174 € (-1,14 %) |
30/04/2026 18:30
Publication Annual Report - Annual Shareholders MeetingLeuven, BELGIUM – April 30, 2026 – 18:30 PM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, has today published its annual report for the financial year 2025. The annual report for the year ending December 31, 2025 is available in the “Investors” section of the Company's website and can also be downloaded as a PDF. On this day as well, the Company has convened its Annual Shareholders' Meeting. The relevant documents pertaining to this Meeting have been published in the section “Shareholders Meetings”. About Oxurion Oxurion NV (Euronext Brussels: OXUR) is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Oxurion's ambition is to build an integrated group of subcontractors serving healthcare players. The Group's headquarters are based in Leuven, Belgium. More information is available at www.oxurion.com. Important information about forward-looking statements Certain statements in this press release may be considered “forward-looking”. Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws. Additional Disclaimer The planned investment in digital assets (such as Bitcoin and Ethereum) exposes the company to specific risks related to volatility, regulatory uncertainty, and cybersecurity. These factors may significantly affect the expected performance of the investments. For further information please contact:
Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière